Adherence to Treatment in Hemophilia

NCT02191436 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2015-10-20

No results posted yet for this study

Summary

Psychosocial factors and adherence to treatment in patients with hemophilia. A multicenter study. Multicenter cross sectional study of patients with hemophilia and their families

Conditions

  • Haemophilia

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY
  • ANA TORRES-ORTUÑO

    lead OTHER

Principal Investigators

  • RUBÉN CUESTA-BARRIUSO, PhD · UNIVERSIDAD CATÓLICA SAN ANTONIO, MURCIA

Eligibility

Min Age
6 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-11-30
Completion
2016-02-29

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02191436 on ClinicalTrials.gov